Elizabeth E. McCarthy
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 5
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 2
- Immune cells in cancer 2
-
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 2
- HIV/AIDS drug development and treatment 2
- Co-authors
- MARK A. TACEY (1 shared paper)Alexis Shub (1 shared paper)Katherine Kedzierska (1 shared paper)Martin Killian (1 shared paper)Martha Lappas (1 shared paper)Timon Damelang (1 shared paper)Elizabeth H. Aitken (1 shared paper)Wina Hasang (1 shared paper)
- Journals
- Cell (4 papers)Nature Communications (4 papers)Science Translational Medicine (2 papers)Proceedings of the National Academy of Sciences (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesAustraliaFrance
In The Last Decade
Elizabeth E. McCarthy
16 papers receiving 669 citations
Elizabeth E. McCarthy's Hit Papers
Peers
Comparison fields: 5 of 73
- Infectious Diseases 263
- Immunology 187
- Oncology 163
- Otorhinolaryngology 25
- Animal Science and Zoology 50
Countries citing papers authored by Elizabeth E. McCarthy
This map shows the geographic impact of Elizabeth E. McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth E. McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth E. McCarthy more than expected).
Fields of papers citing papers by Elizabeth E. McCarthy
This network shows the impact of papers produced by Elizabeth E. McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth E. McCarthy. The network helps show where Elizabeth E. McCarthy may publish in the future.
Co-authors
The 25 scholars most cited alongside Elizabeth E. McCarthy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes Hit paper breakdown → | 2023 | 311 |
| 2 | 2022 | 166 | |
| 3 | 2021 | 57 | |
| 4 | 2021 | 47 | |
| 5 | 2021 | 20 | |
| 6 | 2022 | 18 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 13 | |
| 9 | 2023 | 12 | |
| 10 | 2024 | 11 | |
| 11 | 2016 | 7 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2026 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 |
About Elizabeth E. McCarthy
Elizabeth E. McCarthy is a scholar working on Immunology, Infectious Diseases, Virology, Epidemiology and Nephrology, having authored 17 papers that have together received 683 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Immune Cell Function and Interaction (5 papers), HIV Research and Treatment (3 papers), COVID-19 Clinical Research Studies (2 papers), T-cell and B-cell Immunology (2 papers), HIV/AIDS drug development and treatment (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Infectious Diseases (263 citations), Immunology (187 citations), Oncology (163 citations), Otorhinolaryngology (25 citations) and Animal Science and Zoology (50 citations). Elizabeth E. McCarthy has collaborated with scholars based in United States, Australia and France. Frequent co-authors include MARK A. TACEY, Alexis Shub, Katherine Kedzierska, Martin Killian, Martha Lappas, Timon Damelang, Elizabeth H. Aitken, Wina Hasang, Stephen John Kent and Amy W. Chung. Their work appears in journals such as Cell, Nature Communications, Science Translational Medicine, Proceedings of the National Academy of Sciences and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.